SIH Partners’s AstraZeneca AZN Stock Holding History

SIH Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104M	Buy	549,100 +209,000	+61%	+$39.3M	0.66%	18
2026 Q1	$67.1M	Buy	+340,100	New	+$65.6M	0.89%	25

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SIH Partners's AZN Position: Q2 2026 in Review

SIH Partners increased its AstraZeneca (AZN) stake by 865% in Q2 2026, buying an estimated $15M and bringing the position to 89,209 shares worth $16.9M. The position accounts for 0.11% of the portfolio, ranked #62.

SIH Partners first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

SIH Partners held 89,209 shares of AstraZeneca worth $16.9M as of Q2 2026.
SIH Partners bought 79,960 AstraZeneca shares in Q2 2026, an estimated $15M.
AstraZeneca made up 0.11% of SIH Partners's portfolio in Q2 2026, its #62 holding.
SIH Partners first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.